Monocytes, Macrophages, and Osteoclasts in Osteosarcoma

Abstract

Macrophages appear to have a fundamental role in the pathogenesis of osteosarcoma. These highly diverse plastic cells are subdivided into classical or inflammatory macrophages known as M1 and alternative macrophages, which decrease inflammation and are reparative, called M2. Although primary and metastatic osteosarcomas are infiltrated with M2 macrophages, targeting the M1 macrophages with the immune adjuvant muramyl tripeptide phosphatidyl ethanolamine (MTP-PE) has been the greatest recent therapeutic advance in osteosarcoma. This discrepancy between the presence of M2 and activation of M1 macrophages is intriguing and is likely explained either by the plasticity of M1 and M2 macrophages or nonclassical patrolling monocytes (PMos). To date, MTP-PE has been approved in combination with chemotherapy for nonmetastatic osteosarcoma, but its use in metastatic tumors has not been investigated. In this review, we focus on macrophages, monocytes, and osteoclasts, their role in osteosarcoma, and the potential for targeting these cells in this disease.

<p>Magnesium-doped Nanostructured Titanium Surface Modulates Macrophage-mediated Inflammatory Response for Ameliorative Osseointegration</p>

“…However, M2 macrophages are mainly involved in the mid-late stage of bone tissue regeneration and induce the bone formation by secreting vascular endothelial growth factor (VEGF), bone morphogenetic protein 2 (BMP-2) and other cytokines. 45,46 An experimental model can be established when designing biomaterials of the implants. A beneficial immune status regulated by biomaterials could result in an enhanced osteogenesis activity.…”

Circular RNA circ-NT5C2 acts as an oncogene in osteosarcoma proliferation and metastasis through targeting miR-448

“…However, the overall survival rate of osteosarcoma patients remains pessimistic [ 2 ]. The metastases and relapse of osteosarcoma cells usually cause the poor prognosis and low 5-year survival rate [ 3 ]. Presently, the main method of diagnoses and therapies, tumor excision combined with adjuvant chemotherapy, could achieve limited effects [ 4 ].…”

Effects of CD4⁺ T&nbsp;lymphocytes from ovariectomized mice on bone marrow mesenchymal stem cell proliferation and osteogenic differentiation

“…In PMO, T cells have been identified as a critical cell population in promoting osteoclastogenesis (33). Moreover, as the principle source of osteogenic cells, the proliferation and osteogenic differentiation abilities of BMMSCs are important factors to understand in order to develop improved osteoporosis treatments (34).…”